Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
RNAC
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
RNAC
$6.14
+4.24%
Lists
Call RNAC
Cartesian Therapeutics
RNAC
Back
Lists
Call RNAC
$6.14
+$0.25 · +4.24%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
39%
in three months and
10%
of the way up its 52-week range.
Call RNAC
Loading chart data...
Signal state
RNAC: Cartesian Therapeutics, Inc. Stock Analysis | finqOS